Home / business / Biocon Gets DCGI Nod for Emergency Use of Itolizumab for Treatment of Covid-19 Patients

Biocon Gets DCGI Nod for Emergency Use of Itolizumab for Treatment of Covid-19 Patients

-
Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe COVID-19 complications, it added.

from Top Business News- News18.com
Read The Rest:timesnownews...
Biocon Gets DCGI Nod for Emergency Use of Itolizumab for Treatment of Covid-19 Patients Biocon Gets DCGI Nod for Emergency Use of Itolizumab for Treatment of Covid-19 Patients Reviewed by Team Exprssnews on July 12, 2020 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.

SIGN UP & STAY UPDATED


Subscribe to our newsletters now and stay
up-to-date with exclusive offers.